PPB - Services

Complaints, Feedback and Enquiry

Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products

[featured_image]
  • Version
  • Download 44
  • File Size 140.69 KB
  • File Count 1
  • Create Date February 15, 2022
  • Last Updated February 15, 2022

Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products

These antibiotics used to treat various bacterial infections have been associated with increased risk of disabling adverse drug reactions affecting muscles, tendons and the nervous system.

Attached Files

FileAction
Press Statement on HCTZ 14th March 2019.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published.